StanleyIsaacRapoportMD
Family Medicine • Washington, DCChief, Brain Physiology Metabolism Section at National Institute on Aging
Dr. Rapoport is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3050 Military Rd NW
Apt 935
Washington, DC 20015Phone+1 202-302-9052
Education & Training
NYU Grossman School of MedicineInternship, Internal Medicine, 1959 - 1960
Harvard Medical SchoolClass of 1959
Certifications & Licensure
DC State Medical License 1962 - 2024
Clinical Trials
- Positron Emission Tomography (PET) to Study Brain Signaling Start of enrollment: 2000 Jan 10
Publications & Presentations
PubMed
- 11 citationsQuantitation of Human Whole-Body Synthesis-Secretion Rates of Docosahexaenoic Acid and Eicosapentaenoate Acid from Circulating Unesterified α-Linolenic Acid at Steady ...Yuhong Lin, Joseph R. Hibbeln, Anthony F. Domenichiello, Christopher E. Ramsden, Nicholas M. Salem
Lipids. 2018-05-01 - 8 citations[11 C]arachidonic acid incorporation measurement in human brain: Optimization for clinical use.Francesca Zanderigo, Yeona Kang, Dileep Kumar, Anastasia Nikolopoulou, P. David Mozley
Synapse. 2018-02-01 - 4 citationsValnoctamide, which reduces rat brain arachidonic acid turnover, is a potential non-teratogenic valproate substitute to treat bipolar disorder.Hiren R. Modi, Kaizong Ma, Lisa Chang, Mei Chen, Stanley I. Rapoport
Psychiatry Research. 2017-08-01
Grant Support
- Lipids In Brain Disease And Neuroinflammation: Animal ModelsNational Institute On Aging2011
- Imaging Brain Signal Transduction VIA Arachidonic And Docosahexaenoic AcidsNational Institute On Aging2011
- Imaging Decreased Brain Docosahexaenoic Acid Metabolism And SignalingNational Center For Research Resources2011
- Lipids In Human Brain DiseaseNational Institute On Aging2009–2011
- Lipid Nutrition And The BrainNational Institute On Aging2009–2011
- Brain Imaging In Human Aging, Alzheimer Disease And Other DisordersNational Institute On Aging2009–2011
- Anti-Bipolar Disorder Agents And Brain Arachidonic Acid SignalingNational Institute On Aging2009–2011
- Molecular Mechanisms Of Action Of Lithium And Other Anti-Bipolar Disorder AgentsNational Institute On Aging2009–2010
- Lipids In Brain Disease: Animal ModelsNational Institute On Aging2009–2010
- Imaging Brain Signal Transduction In Vivo With Radiolabeled Arachidonic AcidNational Institute On Aging2009–2010
- Molecular Mechanisms Of Action Of Lithium And Other Anti-Bipolar Disorder AgentsNational Institute On Aging2008
- Lipids In Human Brain DiseaseNational Institute On Aging2008
- Lipids In Brain Disease: Animal ModelsNational Institute On Aging2008
- Anti-Bipolar Disorder Agents And Brain Arachidonic Acid SignalingNational Institute On Aging2008
- Lipid Nutrition And The BrainNational Institute On Aging2007–2008
- Imaging Brain Signal Transduction In Vivo With Radiolabeled Arachidonic AcidNational Institute On Aging2007–2008
- Brain Imaging In Human Aging, Alzheimer Disease And Other DisordersNational Institute On Aging2007–2008
- Mechanisms Of Action Of Lithium And Other Agents In Bipolar DisorderNational Institute On Aging2007
- In Vivo Metabolism Of Liver And Heart.National Institute On Aging2006
- Effects Of Lithium And Other Drugs In Bipolar Disorder ANational Institute On Aging2006
- Brain Phospholipid Metabolism, In Relation To Function,National Institute On Aging2002–2006
- Brain Imaging In Human Aging, Alzheimer Disease And RELANational Institute On Aging2002–2006
- Mechanisms Of Action Of Lithium &Other Drugs In BipolarNational Institute On Aging2005
- In Vivo Metabolism Of Liver And HeartNational Institute On Aging2005
- Brain Imaging In Human Aging And Alzheimer'S DiseaseNational Institute On Aging2005
- Brain Phospholipid Metabolism, In Relation To FunctionNational Institute On Aging2001–2005
- Cerebrospinal Fluid Markers Of Aging And Brain DiseaseNational Institute On Aging2000–2005
- Mechanisms Of Action Of Lithium And Other Drugs In BipolNational Institute On Aging2004
- DOWN Syndrome, Neurodevelopment And NeurodegenerationNational Institute On Aging2004
- DOWN Syndrome, Neurodevelopment And NeurodegenerationNational Institute On Aging2001–2004
- Lithium And Other Antimanic Drugs In Bipolar DisorderNational Institute On Aging2003
- Brain Phospholipid Metabolism And AgingNational Institute On Aging2003
- Brain Imaging In Human Aging And Alzheimers DiseaseNational Institute On Aging2003
- Mechanisms Of Action Of Lithium And Other Antimanic DrugNational Institute On Aging2002
- Gene Expression Of HSC70 And HSP70 In MammalsNational Institute On Aging2001–2002
- Ether Lipids In The Central Nervous SystemNational Institute On Aging2001–2002
- Mechanisms Of Action: Lithium And Other Antimanic DrugsNational Institute On Aging2001
- Brain Imaging In Human Aging And Alzheimer DiseaseNational Institute On Aging2001
- DOWN Syndrome, Neurodevelopment &NeurodegenerationNational Institute On Aging2000
- Cognitive &Neurophysiological Function In Healthy AgingNational Institute On Aging2000
- Molecular Biology Of Brain Aging And DiseaseNational Institute On Aging1998–2000
- Drug Delivery To The Central Nervous SystemNational Institute On Aging1997
- Mechanisms For Alzheimer'S DiseaseNational Institute On Aging1996–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
